-
NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U54 Clinical Trial Optional)
(PAR-22-077)
National Institute on Aging
Application Receipt Date(s): October 17, 2024
-
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
(PAR-22-093)
National Institute on Aging
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): November 12, 2024
-
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional)
(PAR-22-094)
National Institute on Aging
Application Receipt Date(s): November 12, 2024
-
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
(PAS-22-096)
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute on Aging
National Heart, Lung, and Blood Institute
Application Receipt Date(s): January 7, 2025
-
Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed)
(RFA-AG-23-003)
National Institute on Aging
Application Receipt Date(s): March 03, 2022
-
Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)
(RFA-AI-21-079)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): June 3, 2022
-
HEAL Initiative: Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R01- Clinical Trial Not Allowed)
(RFA-DA-22-044)
National Institute on Drug Abuse
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Dental and Craniofacial Research
National Center for Complementary and Integrative Health
Application Receipt Date(s): March 10, 2022
-
HEAL Initiative: Exploratory Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R21- Clinical Trial Not Allowed)
(RFA-DA-22-045)
National Institute on Drug Abuse
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Dental and Craniofacial Research
National Center for Complementary and Integrative Health
Application Receipt Date(s): March 10, 2022
-
PBPK Modeling to Support an Assessment of Bioequivalence for Locally-Acting Drugs in the Gastrointestinal Tract (U01) Clinical Trial Optional
(RFA-FD-22-012)
Food and Drug Administration
Application Receipt Date(s): March 31, 2022, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
-
Physiologically Based Pharmacokinetic Model for Nose-to-Brain Drug Delivery (U01) Clinical Trial Optional
(RFA-FD-22-016)
Food and Drug Administration
Application Receipt Date(s): May 18, 2022
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Cutaneous Pharmacokinetics (PK) Based Approaches to Demonstrate Bioequivalence of Topical Products (U01) Clinical Trial Required
(RFA-FD-22-017)
Food and Drug Administration
Application Receipt Date(s): March 31, 2022, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
-
Building an Integrated Information Technology Infrastructure for State Regulatory Programs (U2F) [Clinical Trial Not Allowed]
(RFA-FD-22-021)
Food and Drug Administration
Application Receipt Date(s): February 22, 2022
-
Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
(RFA-MH-22-135)
National Institute of Mental Health
National Institute on Aging
Application Receipt Date(s): October 17, 2022
-
Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
(RFA-MH-22-136)
National Institute of Mental Health
National Institute on Aging
Application Receipt Date(s): October 15, 2022